Approval · Notice of Compliance 22361 · 2019
CORTROSYN: Notice of Compliance 22361
Issued July 3, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22361
- Date
- July 3, 2019
- Company
- Amphastar Pharmaceuticals IncRancho Cucamonga, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CORTROSYN | Not yet assigned | — |
Medicinal ingredients
- COSYNTROPIN 0.25 MG per VIAL